Boardroom Alpha
Meeting calendar
PBH · Annual meeting · Tuesday, August 5, 2025

Prestige Consumer Healthcare Inc

7 nominees · 3 ballot items.

Election of seven board nominees, advisory vote on named executive officer compensation, and ratification of independent auditor at Prestige's 2025 Annual Meeting.

Market cap
$2.3B
1Y TSR
-43.9%
Board grade
C
Record date
Jun 10, 2025
Filing
DEF 14A
Meeting concluded · Aug 5, 2025

Follow how the vote landed and what changed on Prestige Consumer Healthcare Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of the seven directors nominated by the Board of Directors and named in this Proxy Statement to serve until the 2026 Annual Meeting of Stockholders or until their earlier death, removal or resignation

    ManagementBoard: FOR

    Election of seven board nominees to serve until the 2026 annual meeting and until their successors are elected and qualified.

  2. 2

    Advisory Vote to Approve Named Executive Officer Compensation

    ManagementBoard: FOR

    Non-binding vote to approve the compensation of Prestige's named executive officers as disclosed in the proxy statement.

  3. 3

    Ratification of the Appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm

    ManagementBoard: FOR

    Ratify the appointment of PricewaterhouseCoopers LLP as Prestige's independent registered public accounting firm for the fiscal year ending March 31, 2026.

Director elections

Nominees on the ballot7

Not independent
Tenure on this board
11.1 yrs
Also a director at
Acco Brands Corp (ACCO)
Independent
Tenure on this board
5.4 yrs
Also a director at
Hain Celestial Group Inc (HAIN)Darling Ingredients Inc (DAR)
Independent
Tenure on this board
6.2 yrs
Also a director at
Hain Celestial Group Inc (HAIN)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.11.0%5,191,569$308M
2ARIEL INVESTMENTS, LLC8.6%4,092,721$243M
3VANGUARD PORTFOLIO MANAGEMENT LLC5.9%2,803,828$166M
4DIMENSIONAL FUND ADVISORS LP5.4%2,562,460$152M
5VANGUARD CAPITAL MANAGEMENT LLC4.4%2,092,993$124M
6STATE STREET CORP4.2%1,970,981$117M
7KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC3.7%1,744,694$103M
8Allspring Global Investments Holdings, LLC3.3%1,557,296$90M
9BlackRock, Inc.3.0%1,437,629$85M
10GEODE CAPITAL MANAGEMENT, LLC2.7%1,291,278$77M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Prestige Consumer Healthcare Inc 2025 annual meeting?
Prestige Consumer Healthcare Inc (PBH) holds its 2025 annual shareholder meeting on Tuesday, August 5, 2025.
What is the record date for the Prestige Consumer Healthcare Inc 2025 meeting?
The record date for the Prestige Consumer Healthcare Inc 2025 meeting is Tuesday, June 10, 2025. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Prestige Consumer Healthcare Inc's 2025 meeting?
The board is presenting 7 director nominees at the Prestige Consumer Healthcare Inc 2025 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Prestige Consumer Healthcare Inc 2025 meeting?
Shareholders will vote on 3 proposals at the Prestige Consumer Healthcare Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer